Lori M.B. Laffel
Joslin Diabetes Center
230 Papers
1.3K Citations
Lori M.B. Laffel is an academic researcher from Joslin Diabetes Center. The author has contributed to research in topics: Medicine & Diabetes mellitus. The author has an hindex of 67, co-authored 146 publications. Previous affiliations of Lori M.B. Laffel include Children's Memorial Hospital & Cincinnati Children's Hospital Medical Center.
Chat about Author
Papers
Improved CGM Glucometrics and More Visits in Pediatric Type 1 Diabetes using Telemedicine During 1 Year of COVID-19.
TL;DR: Children and adolescents with T1D using CGM before and during the COVID-19 pandemic showed an overall increase in visit frequency using primarily telemedicine-based care and improved CGM glucometrics.
3
Changing prescribing patterns of type 2 diabetes medications from 2002-2010: an electronic health record-based evaluation.
Sanjeev N. Mehta,Allison B. Goldfine,Martin J. Abrahamson,Richard DiVincenzo,Lori M.B. Laffel +4 more
TL;DR: Evaluations of EHR data represent a cost-effective method for evaluating diabetes medications with new Food and Drug Administration warnings or indications for adults with diabetes from 2002–2010.
Exercise: it isn't just child's play when it comes to managing type 1 diabetes.
TL;DR: It appears that motor manifestations and behaviors that are classified as seizures in ELBW infants are associated with adverse outcome, irrespective of electrophysiological confirmation, and it is confirmed that seizures are probably more common among preterm infants than generally considered.
3
Diabetes Distress in Emerging Adulthood: Content Validity of the Problem Areas in Diabetes—Emerging Adult Version (PAID-EA) Using Qualitative Analysis
TL;DR: Emerging adulthood is a period in which the future should hold infinite possibility, but young people with T1DM describe a staggering fear of the future with markedly limited possibilities, supporting the need to measure the developmental-stage-specific experience of DD as captured on the PAID-EA.
3
Long-Term Retention of Young Adult Study Participants with Youth-Onset Type 2 Diabetes: Results from the TODAY2 Study
Rachelle Gandica,Ruth S. Weinstock,Mihili Gunaratne,Silva A. Arslanian,L. Doherty,Mitchell E. Geffner,Lori M.B. Laffel,Janine A. Higgins +7 more
TL;DR: The Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) trial examined the effects of three treatment arms in a group of racially and ethnically diverse adolescents and youth with type 2 diabetes mellitus as mentioned in this paper .
2